I n recent decades, there has been improvement in both survival and neurodevelopment of children with single ventricle who have been palliated with use of the Fontan procedure. Nonetheless, these patients remain at increased risk of cognitive and behavioral impairments. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] Although in some studies the deficits are modest in severity, 12,13 they are broad-based and include reduced IQ scores, learning disorders, visuomotor integration deficits, attention deficit hyperactivity disorder (ADHD), and reduced quality of life. 14, 15 The reported deficits have tended to be greater among patients with hypoplastic left heart syndrome (HLHS) than in those with other forms of univentricular heart, [16] [17] [18] with occasional exceptions. 19 Longitudinal studies of children with other forms of congenital heart disease (CHD) have shown that the full range of their neurodevelopmental morbidity can be appreciated only if follow-up extends at least into adolescence, when patients face the complex academic and social challenges associated with this developmental epoch. 20, 21 This period, with its greater demands for self-regulation and selforganization, may be particularly challenging for Fontan patients.
We report here on a cross-sectional study of adolescents who underwent the Fontan procedure to palliate complex CHD. Neurodevelopmental outcomes and anatomic brain magnetic resonance imaging (MRI) at 10 to 19 years of age are compared with those of normative populations or those of a locally recruited healthy adolescent referent group. We hypothesized that patients whose first operation was a Norwood procedure versus another operation would have worse neurodevelopmental outcomes because of a greater likelihood of disturbed cerebral perfusion in utero and of neonatal open heart surgery. In addition, we report on operative, medical, and genetic risk factors for worse neurodevelopmental outcomes in these patients.
Methods Subjects
We enrolled Fontan subjects from 2010 to 2012 at a single institution. Inclusion criteria were (1) age 10 to 19 years at the time of enrollment, (2) diagnosis of single ventricle lesion, and (3) history of Fontan procedure. We excluded patients who met any of the following criteria: (1) disorders that would prevent successful completion of the planned study testing (eg, pacemaker, metal implants preventing MRI); (2) lack of reading fluency by primary caregiver in English, which is the only language for which questionnaires have been validated; (3) foreign residence; (4) cardiac transplantation; and (5) cardiac surgery within 6 months of testing. The study was approved by the institutional review board, and we obtained informed consent of parent or guardian (for subjects aged <18 years) or of subjects (aged ≥18 years), as well as assent of study participants aged <18 years. A separate informed consent was obtained from parents to obtain their DNA.
We also recruited healthy referent subjects of a similar age from local pediatric practices, from our institutional adolescent clinic, and through posted notices. Because these subjects were recruited primarily for the purpose of comparing brain MRI, we applied exclusion criteria derived from the National Institutes of Health's MRI study of normal brain development. 22 Data from these referent subjects were also used for comparison with Fontan subjects on psychometric tests for which normative data are not available.
Medical Data Obtained
By using medical record reviews, questionnaires, and family interviews, we recorded data on family history, events before the first operation, the number and types of cardiovascular interventions, intraoperative variables for all operations (eg, total support and circulatory arrest times), and major postoperative or postcatheterization complications (eg, car- 
Neuropsychological Assessment
The assessment battery included tests of general intelligence, academic achievement, memory, executive functions, visuospatial skills, attention, and social cognition. The specific assessments administered, and the scores derived from each, are described next. chosen to maintain a streamlined total scan time.
General intelligence
Brain MRI results were read by a single blinded neuroradiologist (R.L.R.). Images were assessed by visual inspection to rate the quality of data and to identify abnormalities. Abnormalities were classified by origin (acquired or developmental), type (infarction, mineralization, iron deposition, myelination delay, ventriculomegaly, or abnormal T2-weighted signal hyperintensity), extent (focal or diffuse), and anatomic location.
Genetics Evaluation
Genetics evaluation of the Fontan patients included examination by a clinical geneticist (A.E.R.), medical record review, and blood sampling for a chromosomal microarray, performed on an oligonucleotide-based Agilent 244k platform array that detected deletions or duplications at multiple targeted sites throughout the genome. It contained probes to detect copy number changes as small as 150 kb between the target regions. We classified subjects as having a possible or definite genetic abnormality if they met ≥1 of the following criteria: a relevant known genetic diagnosis at time of enrollment, a pathogenic variant on array, a variant of unknown significance on array, and/or syndromic presentation (defined as dysmorphic features and/or extracardiac birth defects).
Statistical Methods
Comparisons of operative and medical risk factors, special services, and MRI findings were performed by using Fisher's exact tests for categorical measures and either ANOVA for continuous measures (when normally distributed) or KruskalWallis tests (when non-normal). Comparisons of NYHA functional class were made with Cochran-Armitage trend tests. Neuropsychological outcomes of Fontan adolescents, collectively and stratified by Norwood procedure, were compared with available expected population means by using 1-sample t tests. Linear regression with adjustment for concurrent family social status (ie, Hollingshead Four-Factor Index of Social Status) was used to compare neuropsychological outcomes of Fontan adolescents with those of the referent group when a population mean was not available (ie, Rey-Osterrieth Complex Figure, Sense of Direction Scale, Reading the Mind in the Eyes Test-Revised, Toronto Alexithymia Scale, Autism Spectrum Quotient), as well as for comparisons between Norwood groups.
We used linear regression analyses to identify earlier risk factors for neuropsychological outcomes in Fontan adolescents among the predictors listed in Table 1 (except cardiac diagnosis, continuous age at operation, indicator for use of deep hypothermic circulatory arrest at first operation, NYHA functional class, and use of special services) after adjusting for family social status and Norwood procedure. We did not adjust for the large number of types of anatomic heart disease because, with the exception of HLHS, the number of patients in each category was small, and the type of heart lesion and surgical variables were collinear. For closed procedures, values of deep hypothermic circulatory arrest and total support duration were set to 0. Predictors associated with neuropsychological outcomes at a level of P<0.20 were considered for stepwise backward regression, for which P<0.05 served as the significance criterion while adjusting for family social status and Norwood procedure. A similar procedure was used to identify factors predicting MRI outcomes by using logistic regression while adjusting for genetic abnormality.
Results

Cardiac Status and History
Among 362 Fontan adolescents who met the eligibility criteria, 116 (32%) were followed at other institutions or lost to follow-up. Of the 246 invited to participate, 90 (35%) declined to participate. Patients who consented versus declined did not differ in sex, race, or diagnosis of HLHS. Our study cohort consisted of the remaining 156 adolescents, as well as 111 referent subjects. Table 1 summarizes the medical histories of the Fontan adolescents. Most (64%) had undergone staged palliation, with a median of 3 operations (range 1-5), and 40% had HLHS or another single right ventricle anomaly requiring the Norwood procedure.
Compared with referent subjects, Fontan subjects had lower birth weight (3.3AE0.6 versus 3.5AE0.6 kg, P=0.01), were of younger gestational age (38.9AE2.2 versus 39.6AE1.3 weeks, P=0.007), were more likely to be white (93% versus 83%, P=0.03), had lower concurrent family social status (50AE13 versus 53AE10, P=0.02), and were significantly younger at developmental testing (14.5AE2.9 versus 15.3AE1.8 years, P=0.008), but they had similar distributions of sex and ethnicity. Fontan adolescents who underwent the Norwood procedure, compared with those who did not, were less likely to have genetic abnormalities (P=0.02), were more likely to have had neonatal heart surgery (P<0.001), were more likely to have had a first operation that was performed on bypass (P<0.001), had longer deep hypothermic circulatory arrest and total support durations at first operation (P<0.001 each), and had more operative complications (P<0.001).
Most Fontan adolescents were in NYHA functional class II (63%), while 29% were in class I, and 8% were in class III. None were in class IV. In contrast, most referent subjects were in NYHA functional class I (95%), with the remaining 5% in class II (P<0.001). NYHA functional class did not differ between Fontan patients who had undergone the Norwood procedure versus those who had not.
Among Fontan adolescents, medical histories included seizures (n=23, 15%), stroke (n=19, 12%), choreoathetosis (n=1, 1%), and meningitis (n=1, 1%). Parents reported that 22% (n=34) had been diagnosed with ADHD and 37% (n=57) with a learning disability. Medications in the Fontan group included therapies for attention-deficit disorder or ADHD (n=15, 10%) and psychotropic agents (n=13, 8%). Three Fontan adolescents (2%) reported use of both ADHD and psychotropic medications.
Genetics Evaluation
Of 156 enrolled subjects, 6 had a genetic diagnosis at the time of enrollment (22q11 deletion, CHARGE syndrome [represents coloboma, heart defect, atresia choanae (also known as choanal atresia), retarded growth and development, genital abnormality, and ear abnormality], hyperphenylalaninemia, Kartagener syndrome, and 2 cases of VACTERL [vertebral defects, anal atresia, cardiac defects, tracheoesophageal fistula, renal anomalies, and limb abnormalities]), and 134 had a physical examination completed by a medical geneticist (A.E.R.) and array comparative genomic hybridization (CGH) analysis. Ten percent were classified as having a definite genetic abnormality (6 subjects with a genetic diagnosis at the time of enrollment and 10 subjects with a pathogenic variant on array CGH). An additional 31% were classified as having a possible genetic abnormality (17 with a variant of unknown significance on array CGH and 32 with normal array but syndromic features). The Norwood and nonNorwood groups did not differ significantly with respect to genetic diagnosis at the time of enrollment or abnormal array CGH. However, the Norwood group was less likely to have Continued syndromic features than were the non-Norwood group (18% versus 42%, P=0.003).
On array CGH, 7 Fontan subjects had 2 abnormalities, 2 subjects had 3 abnormalities, and 1 subject had 4 abnormalities, for a total of 55 variants in 41 probands (Table 2) . Of the variants, 25% were judged to be pathogenic (3 syndromic subjects and 7 nonsyndromic subjects); 44% were variants of unknown significance (7 syndromic subjects and 12 nonsyndromic subjects); and 31% were thought to be likely benign (5 syndromic subjects and 12 nonsyndromic subjects). The overall rate of pathogenic copy number variant (CNV) detection was 7% (10/134). Of the pathogenic variants, 7 were thought to explain the CHD (3 cases of hypoplastic right ventricle, 3 cases of hypoplastic left ventricle, and 1 case of tricuspid atresia). The remaining 3 CNVs were clinically significant for extracardiac anomalies but without a clear association to CHD based on the published literature and what is known biologically about the genes in the region. The Compared with Fontan adolescents without genetic abnormalities, those with definite or possible genetic abnormalities were more likely to have received special services, including early intervention, occupational therapy, physical therapy, special education, and psychotherapy or counseling (data not shown). Because we grouped those with definite and possible genetic abnormalities together in the "genetic abnormality group," our analysis may underestimate the effect of a genetic diagnosis on neuropsychological outcomes. Table 3 presents the neuropsychological scores of all Fontan adolescents, collectively and stratified by Norwood procedure, along with the results of comparisons with the expected population mean scores and the scores of the referent group. Table 4 presents the percentages of adolescents in the Norwood and non-Norwood groups with neuropsychological scores that were >1 or >2 SDs below the expected mean and parent or teacher ratings of executive function that were in the range considered to be clinically significant. As the tables illustrate, the scores of the Fontan group as a whole on most tests were significantly worse than the expected population means or the scores of the referent group. Therefore, the following section focuses on comparisons of the scores of the Norwood and non-Norwood groups.
Neuropsychological Assessment
General Intelligence
The Norwood group scored lower than the non-Norwood group on all composites except Working Memory. More than 2 (43%) in 5 of the Norwood group had a Full-Scale IQ score ≤85 (compared with an expected frequency in the general population of 16%) and 17% scored ≤70 (compared with the expected 2%). One (24%) in 4 adolescents in the non-Norwood group had a Full-Scale IQ score ≤85 and 8% scored ≤70.
Academic Achievement
Reading and Mathematics Composite scores were significantly lower for the Norwood group than for the 
Memory
The overall mean scores of adolescents in the Norwood and non-Norwood groups did not differ significantly, though the mean scores of the Norwood group were %0.5 SD lower for both age groups. In the Norwood group on the Children's Memory Scale, %2 (41%) in 5 scored ≤85 and 25% scored ≤70, while in the non-Norwood group, 28% scored ≤85 and 12% scored ≤70. On the Wechsler Memory Scale, 64% of the Norwood group scored ≤85 and 27% scored ≤70, while in the Norwood group, 28% scored ≤85 and 8% scored ≤70. The mean executive function summary score of the Norwood group was lower than the mean score of the non-Norwood group (P<0.05). In the Norwood group, 35% scored ≥3 points below 10 (ie, %>1 SD), and 5% scored ≥6 points below 10 (ie, %>2 SDs). In the non-Norwood group, 14% scored ≥3 points below the expected mean and 4% scored ≥6 points below the expected mean. On the BRIEF, the mean General Executive Composite scores of the Norwood and nonNorwood groups did not differ significantly for any of the 3 informants, though the scores of the Norwood group tended to be somewhat higher. On the parent BRIEF, 35% of the Norwood group scored ≥65 (ie, "potential clinical significance"), compared with 32% of the non-Norwood group. On the teacher BRIEF, these figures were 44% and 27%, respectively, and on the self-report BRIEF, they were 12% and 10%, respectively.
Visuospatial Skills
The scores of the Norwood and non-Norwood groups did not differ significantly for the Test of Visual-Perceptual Skills summary or the Sense of Direction Scale, but the Norwood group did score lower on all scales of both the copy and immediate recall trials of the Rey-Osterrieth Complex Figure ( P=0.001 to 0.007).
Attention
Although the mean score of the Norwood group was higher than that of the non-Norwood group, the difference was not significant. Approximately 2 (40%) in 5 of adolescents in the Norwood group and 29% of adolescents in the non-Norwood group scored ≥66, which is considered to be "moderately atypical."
Social Cognition
The scores of the Norwood and non-Norwood groups did not differ significantly on the Toronto Alexithymia Scale (total score), but the Norwood group did score significantly worse on the Reading the Mind in the Eyes Test-Revised (P=0.02) and the Autism Spectrum Quotient (P=0.03).
MRI Data
MRI data were available for 144 adolescents who underwent the Fontan procedure and 105 referents. The frequency of any abnormality was 11-fold greater among the patients than the referents (66% versus 6%, P<0.001; Table 5 ). The majority of abnormalities were focal or multifocal, with most involving brain mineralization or iron deposits, and 19 (13%) patients had evidence of a stroke. Among these, stroke had been previously diagnosed in only 12 patients (60%). Diffuse abnormalities were also more common in the Fontan group (9% versus 2%, P=0.03), with the majority consisting of abnormal T2-weighted hyperintensities. The Norwood and non-Norwood groups did not differ in the frequency of MRI abnormalities.
Predictors of Neuropsychological and MRI Outcomes
Risk factors of selected neuropsychological test scores, after adjustment for concurrent family social status and Norwood status, are presented in Table 6 . Longer total support or deep hypothermic circulatory arrest duration at first operation was significantly associated with lower scores on each of the Wechsler Intelligence Scale composites (P≤0.01 for each).
Executive functions, as measured by both parent and teacher BRIEFs, was worse (ie, higher scores) in patients with ≥6 operative complications, compared with those with no complications (P=0.02 and 0.006, respectively). Scores on several end points were worse among patients who were of Hispanic ethnicity, had a possible or definite genetic abnormality, required more operations, experienced more operative complications, required more catheterizations, experienced more catheterization complications, were of younger gestational age, had an open first operation (versus shunt), had occurrence of seizure, and were younger at developmental testing.
Stepwise logistic regression analyses were conducted of 4 MRI end points (any abnormality, focal/infarction or atrophy, brain mineralization/iron deposit, any diffuse abnormality). The odds of any diffuse abnormality were associated with operative complications (P=0.009), with marginally greater odds among patients who had ≥6 operative complications compared with those with no operative complications (odds ratio=7.8, 95% CI 0.8 to 71.9, P=0.07) and significantly greater odds compared with those with 1 to 5 operative complications (odds ratio=7.0, 95% CI 1.9 to 25.9, P=0.004) after adjusting for the presence of a genetic abnormality. We did not find any statistically significant risk factors for the categories of any abnormality, focal/infarction or atrophy, or brain mineralization. The CIs for all odds ratios were wide, however, because of the small number of patients in many categories.
We also explored whether MRI findings added additional predictive ability to the models of neuropsychological test scores presented in Table 6 . Focal infarction or atrophy predicted higher (worse) parent BRIEF scores (7.4AE2.7, P=0.008), higher (worse) parent Conners' ADHD/Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition ADHD Index scores (8.3AE3.1, P=0.008), and higher (worse) Autism Spectrum Quotient scores (2.8AE1.3, P=0.03), relative to subjects without these MRI findings, respectively. The presence of brain hemosiderin/iron deposits was not a predictor of worse neurocognitive outcomes. The presence of diffuse abnormalities on anatomic MRI was not associated with any neurocognitive score, with limited power.
Discussion
In our study of adolescents who had undergone the Fontan procedure, we found that about two-thirds (66%) had an abnormality on structural brain MRI, and 13% showed evidence of a stroke. Fontan adolescents scored significantly lower than population norms and a healthy local referent group in all of the neuropsychological domains assessed, and scores of adolescents with HLHS or other single right ventricle abnormalities who underwent the Norwood procedure were generally lower than those of adolescents who did not undergo the Norwood procedure and were significantly lower in the domains of general intelligence, reading and math achievement, and executive function. Some aspects of neuropsychological function in Fontan patients appeared to be more impaired than others. In terms of intelligence, verbal skills appeared to be stronger than perceptual reasoning skills. Processing speed, which is based on the subtests of Coding and Symbol Search, was also a relative weakness. With regard to academic achievement, substantial percentages of adolescents had reading and mathematics skills that were significantly lower than expected based on their FullScale IQ scores. Fontan patients performed more poorly than referents in mnemonic function in what appeared to be a development-dependent fashion. In terms of executive functions, parents and teachers perceived greater executive dysfunction in the adolescents than did the adolescents themselves. As many studies of children with CHD have reported, visuospatial skills were particularly weak. The frequency of parent-reported ADHD-related behaviors was high.
Like children with other forms of CHD, 20, 21 Fontan patients manifested difficulties in social cognition, scoring worse than the referents in their ability to identify the emotions behind facial expressions (Reading the Mind in the Eyes Test) and a dimensional assessment of the ability to recognize one's own emotions (Toronto Alexithymia Scale). Compared with referents, they showed concrete, "externally-oriented thinking" (eg, endorsing statements such as, "I prefer talking to people about their daily activities rather than their feelings" and "Looking for hidden meanings in movies or plays distracts from their enjoyment"). Abnormalities on MRI were detected at a frequency 11-fold higher in the Fontan patients than in the referents, with focal/multifocal abnormalities being much more common than diffuse abnormalities. Previous studies have 41 including periventricular leukomalacia. 38 In one study, nearly three-fourths of patients with HLHS showed new or worsened ischemic lesions (including periventricular leukomalacia) postoperatively. 42 For a substantial minority (40%) of the adolescents in our cohort who showed evidence of a stroke, this finding had not been previously reported, highlighting that its occurrence can be clinically silent. Among those who underwent genetic evaluation and testing with chromosomal microarray, 7% had a pathogenic finding. There is limited information about the diagnostic yield of chromosomal microarray in CHD. De novo CNVs have been reported in HLHS. 43 Of the previously published loci thought to confer a significant risk for CHD, [44] [45] [46] 3 members of our cohort had overlapping CNVs: a 15q11.2 deletion previously reported in 12 cases with CHD, 44 a 2q13 duplication, 47 and a 4q35.1 terminal deletion previously associated with CHD. 48 The remaining 3 CNVs were not previously described, but unaffected parents were tested and all 3 were de novo rare CNVs (3q28 deletion, 7q36.3 deletion, and 9q31.2 duplication). Our 5% (7/134) pathogenic CNV detection rate for loci with significant risk for CHD is at the lower end of published estimates of 5% to 10%. 44, [46] [47] [48] [49] [50] This is most likely because of the relatively high number of variants of unknown significance for which parent samples were not available to determine de novo status and a more complete assessment for pathogenicity. Our study should be viewed in light of its limitations. The cross-sectional design required retrospective record review of medical history. Further, some patients did not have their surgeries or catheterizations performed at our institution, limiting the comprehensiveness of medical information available to us. In particular, the total number of hospital admissions or total lengths of stays across admissions as a measure of global morbidity could not be analyzed. Approximately half of potential subjects who were eligible for this study were either followed elsewhere and lost to our follow-up or declined participation; participants may have been biased toward either better or worse outcomes than the general Fontan population. Although all subjects were invited to participate in the genetic arm of the study, only 87% chose to do so. Moreover, known single gene point mutations, an established cause of syndromic and nonsyndromic CHD, would not be detected by array comparative genomic hybridization. We did not adjust for multiple testing and many variables were collinear in this exploratory analysis. In addition, we did not validate our risk factor analysis in an independent sample. Finally, anatomic brain MRI findings in Fontan patients were compared with those in optimal referents without known risk factors for brain injury. Anatomic brain MRI is relatively insensitive for delineating subtle central nervous system injury, and further reports describing abnormalities of brain structure, microstructure, and function in this cohort are in process.
In summary, we found that abnormalities of neuropsychological performance in patients who have undergone the Fontan procedure are common and generally more severe than those of children with 2-ventricle congenital heart defects. Moreover, larger SDs of the scores in Fontan patients, compared with those of the referents, indicate great variability of outcomes within the Fontan population. The neurodevelopmental deficits and high frequency of structural brain and genetic abnormalities in the Fontan cohort highlight the need for continued research on interventions to improve long-term outcomes in this high-risk group. 
